{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:53:22Z","timestamp":1792029202131,"version":"4.4.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004504","name":"Lietuvos Mokslo Taryba","doi-asserted-by":"publisher","award":["S-SEN-20-7"],"award-info":[{"award-number":["S-SEN-20-7"]}],"id":[{"id":"10.13039\/501100004504","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Efforts to understand the interplay between m6A (N6-methyladenosine) modification and long non-coding RNAs (lncRNAs) in the pathogenesis of various diseases, including cancer, have recently attracted considerable attention.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Herein, we profiled epitranscriptome-wide m6A modifications within lncRNAs at single m6A site resolution across different grades of gliomas (Glioblastomas (GB): <jats:italic>n<\/jats:italic>\u2009=\u200917, Low grade gliomas (LGG): <jats:italic>n<\/jats:italic>\u2009=\u20099) using direct RNA long-read sequencing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Our analysis demonstrated that, 1) 98.5% of m6A-modified RRACH motifs were present within mRNA transcripts, while only 1.16% were conspicuous within lncRNAs. Importantly, LGGs exhibited a higher m6A abundance (23.73%) compared to the GB transcriptome (15.84%). 2) The m6A profiles of lncRNAs differed significantly between gliomas, with unsupervised cluster analysis revealing two clusters (C1, C2). LGG dispersed between C1 and C2 clusters while GB stayed mainly in C1. Clinical feature association analysis between m6A clusters showed the tendency of m6A to be associated with higher malignancy grade (<jats:italic>p<\/jats:italic>\u2009=\u20090.053), while significant association was observed with higher Ki-67 proliferation index (<jats:italic>p<\/jats:italic>\u2009=\u20090.04), and tumor location (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01). Specifically, brain tumors located in cerebellum (<jats:italic>n<\/jats:italic>\u2009=\u20093) were highly m6A modified on lncRNAs as compared to tumors in other locations (frontal lobe, <jats:italic>n<\/jats:italic>\u2009=\u20095, <jats:italic>p<\/jats:italic>\u2009=\u20090.003; frontotemporal lobe, <jats:italic>n<\/jats:italic>\u2009=\u20092, <jats:italic>p<\/jats:italic>\u2009=\u20090.08; occipital, <jats:italic>n<\/jats:italic>\u2009=\u20092, <jats:italic>p<\/jats:italic>\u2009=\u20090.038; parietal, <jats:italic>n<\/jats:italic>\u2009=\u20092, <jats:italic>p<\/jats:italic>\u2009=\u20090.007; temporal, <jats:italic>n<\/jats:italic>\u2009=\u200911, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Cox regression analysis showed that the status of lncRNAs m6A modifications had no significant value in predicting post-surgical survival time in our GB or LGG cohorts. The trend of higher lncRNA expression in m6A methylated group was observed for the majority of lncRNAs, while only MIR9-1HG (<jats:italic>r<\/jats:italic>\u2009=\u20090.439, <jats:italic>p<\/jats:italic>\u2009=\u20090.028) and ZFAS1 (<jats:italic>r<\/jats:italic>\u2009=\u20090.609, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) m6A showed statistically significant positive correlations in gliomas. A high-resolution m6A study revealed that mRNA levels of m6A writers and erasers in gliomas do not reflect global m6A methylation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Overall, we provide evidence that m6A lncRNAs are strongly modulated in gliomas, representing biologically distinct subgroups. Ten novel differentially methylated lncRNAs were identified in gliomas, which might exert regulatory role in glioma cells. These findings may provide a basis for further deeper research on the role of m6A lncRNAs in gliomas.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s10020-025-01254-x","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T09:14:23Z","timestamp":1747473263000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["m6A-lncRNA landscape highlights reduced levels of m6A modification in glioblastoma as compared to low-grade glioma"],"prefix":"10.1186","volume":"31","author":[{"given":"Giedrius","family":"Steponaitis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rugile","family":"Dragunaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rytis","family":"Stakaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arimantas","family":"Tamasauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daina","family":"Skiriute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,17]]},"reference":[{"key":"1254_CR1","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1200\/JCO.2017.73.0119","volume":"35","author":"BM Alexander","year":"2017","unstructured":"Alexander BM, Cloughesy TF. Adult Glioblastoma. J Clin Oncol. 2017;35:2402\u20139.","journal-title":"J Clin Oncol"},{"key":"1254_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nature24678","volume":"552","author":"I Barbieri","year":"2017","unstructured":"Barbieri I, Tzelepis K, Pandolfini L, Shi J, Mill\u00e1n-Zambrano G, Robson SC, et al. Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control. Nature. 2017;552:126\u201331.","journal-title":"Nature"},{"key":"1254_CR3","doi-asserted-by":"publisher","unstructured":"Baspinar Y, Elmaci I, Ozpinar A, Altinoz MA. Long non-coding RNA MALAT1 as a key target in pathogenesis of glioblastoma. Janus faces or Achilles\u2019 heal?. Gene. 2020;739:144518. https:\/\/doi.org\/10.1016\/j.gene.2020.144518. Epub 2020 Feb 28. PMID: 32119915.","DOI":"10.1016\/j.gene.2020.144518"},{"key":"1254_CR4","doi-asserted-by":"crossref","unstructured":"Boccaletto P, Stefaniak F, Ray A, Cappannini A, Mukherjee S, Purta E, et al. MODOMICS: a database of RNA modification pathways. 2021 update. Nucleic Acids Res. 2022;50:D231\u20135.","DOI":"10.1093\/nar\/gkab1083"},{"key":"1254_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2017.11.018","volume":"415","author":"X Cai","year":"2018","unstructured":"Cai X, Wang X, Cao C, Gao Y, Zhang S, Yang Z, et al. HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g. Cancer Lett. 2018;415:11\u20139.","journal-title":"Cancer Lett"},{"key":"1254_CR6","doi-asserted-by":"crossref","unstructured":"Cao X, Geng Q, Fan D, Wang Q, Wang X, Zhang M, et al. m6A methylation: a process reshaping the tumour immune microenvironment and regulating immune evasion. Mol Cancer. 2023;22.","DOI":"10.1186\/s12943-022-01704-8"},{"key":"1254_CR7","doi-asserted-by":"crossref","unstructured":"Cappannini A, Ray A, Purta E, Mukherjee S, Boccaletto P, Moafinejad SN, et al. MODOMICS: a database of RNA modifications and related information. 2023 update. Nucleic Acids Res. 2024;52:D239\u201344","DOI":"10.1093\/nar\/gkad1083"},{"key":"1254_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, et al. DNA methylation-based classification of central nervous system tumours. Nature. 2018;555:469\u201374.","journal-title":"Nature"},{"key":"1254_CR9","doi-asserted-by":"crossref","unstructured":"Chai RC, Wu F, Qi-Xue Wang, Zhang S, Zhang KN, Liu YQ, et al. m 6 A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas. Aging. 2019;11:1204\u201325.","DOI":"10.18632\/aging.101829"},{"key":"1254_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1200\/EDBK_158869","volume":"35","author":"SM Chang","year":"2016","unstructured":"Chang SM, Cahill DP, Aldape KD, Mehta MP. Treatment of Adult Lower-Grade Glioma in the Era of Genomic Medicine. Am Soc Clin Oncol Educ Book. 2016;35:75\u201381.","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"1254_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.canlet.2021.04.020","volume":"511","author":"YZ Chang","year":"2021","unstructured":"Chang YZ, Chai RC, Pang B, Chang X, An SY, Zhang KN, et al. METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-\u03baB to promote the malignant progression of IDH-wildtype glioma. Cancer Lett. 2021;511:36\u201346.","journal-title":"Cancer Lett"},{"key":"1254_CR12","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/hep.29683","volume":"67","author":"M Chen","year":"2018","unstructured":"Chen M, Wei L, Law CT, Tsang FHC, Shen J, Cheng CLH, et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology. 2018;67:2254\u201370.","journal-title":"Hepatology"},{"key":"1254_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/neuonc\/noy123","volume":"21","author":"HJ Cho","year":"2019","unstructured":"Cho HJ, Zhao J, Jung SW, Ladewig E, Kong DS, Suh YL, et al. Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma. Neuro Oncol. 2019;21:47\u201358.","journal-title":"Neuro Oncol"},{"key":"1254_CR14","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1016\/j.celrep.2017.02.059","volume":"18","author":"Q Cui","year":"2017","unstructured":"Cui Q, Shi H, Ye P, Li L, Qu Q, Sun G, et al. m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells. Cell Rep. 2017;18:2622\u201334.","journal-title":"Cell Rep"},{"key":"1254_CR15","doi-asserted-by":"publisher","first-page":"D988","DOI":"10.1093\/nar\/gkab1049","volume":"50","author":"F Cunningham","year":"2022","unstructured":"Cunningham F, Allen JE, Allen J, Alvarez-Jarreta J, Amode MR, Armean IM, et al. Ensembl 2022. Nucleic Acids Res. 2022;50:D988\u201395.","journal-title":"Nucleic Acids Res"},{"key":"1254_CR16","doi-asserted-by":"crossref","unstructured":"Danecek P, Bonfield JK, Liddle J, Marshall J, Ohan V, Pollard MO, et al. Twelve years of SAMtools and BCFtools. Gigascience. 2021;10.","DOI":"10.1093\/gigascience\/giab008"},{"key":"1254_CR17","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11112","volume":"485","author":"D Dominissini","year":"2012","unstructured":"Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485:201\u20136.","journal-title":"Nature"},{"key":"1254_CR18","doi-asserted-by":"crossref","unstructured":"Dong Z, Cui H. The Emerging Roles of RNA Modifications in Glioblastoma. Cancers 2020, Vol 12, Page 736. 2020;12:736.","DOI":"10.3390\/cancers12030736"},{"key":"1254_CR19","doi-asserted-by":"crossref","unstructured":"Ewels PA, Peltzer A, Fillinger S, Patel H, Alneberg J, Wilm A, et al. The nf-core framework for community-curated bioinformatics pipelines. Nature Biotechnology 2020 38:3. 2020;38:276\u20138.","DOI":"10.1038\/s41587-020-0439-x"},{"key":"1254_CR20","doi-asserted-by":"crossref","unstructured":"Fazi F, Fatica A. Interplay Between N 6-Methyladenosine (m6A) and Non-coding RNAs in Cell Development and Cancer. Front Cell Dev Biol. 2019;7 JUN.","DOI":"10.3389\/fcell.2019.00116"},{"key":"1254_CR21","doi-asserted-by":"crossref","unstructured":"Feng P, Liu S, Yuan G, Pan Y. Association of M2 macrophages with EMT in glioma identified through combination of multi-omics and machine learning. Heliyon. 2024;10.","DOI":"10.1016\/j.heliyon.2024.e34119"},{"key":"1254_CR22","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1126\/science.aau1646","volume":"361","author":"M Frye","year":"2018","unstructured":"Frye M, Harada BT, Behm M, He C. RNA modifications modulate gene expression during development. Science. 2018;361:1346\u20139.","journal-title":"Science"},{"key":"1254_CR23","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00701-009-0286-5","volume":"151","author":"G Grahovac","year":"2009","unstructured":"Grahovac G, Tomac D, Lambasa S, Zoric A, Habek M. Cerebellar glioblastomas: Pathophysiology, clinical presentation and management. Acta Neurochir (Wien). 2009;151:653\u20137.","journal-title":"Acta Neurochir (Wien)"},{"key":"1254_CR24","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/cam4.4531","volume":"11","author":"S Han","year":"2022","unstructured":"Han S, Qi J, Fang K, Wang H, Tang Y, Wu D, et al. Characterization of m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration in acute myeloid leukemia. Cancer Med. 2022;11:1413\u201326.","journal-title":"Cancer Med"},{"key":"1254_CR25","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","volume":"37","author":"H Huang","year":"2020","unstructured":"Huang H, Weng H, Chen J. m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer. Cancer Cell. 2020;37:270\u201388.","journal-title":"Cancer Cell"},{"key":"1254_CR26","doi-asserted-by":"crossref","unstructured":"Jacob R, Zander S, Gutschner T. The dark side of the epitranscriptome: Chemical modifications in long non-coding rnas. International Journal of Molecular Sciences. 2017;18.","DOI":"10.3390\/ijms18112387"},{"key":"1254_CR27","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathmechdis-051122-110348","volume":"19","author":"MA Jayaram","year":"2024","unstructured":"Jayaram MA, Phillips JJ. Role of the Microenvironment in Glioma Pathogenesis. Annu Rev Pathol. 2024;19:181\u2013201.","journal-title":"Annu Rev Pathol"},{"key":"1254_CR28","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.molmed.2018.07.010","volume":"24","author":"RV Kadumuri","year":"2018","unstructured":"Kadumuri RV, Janga SC. Epitranscriptomic Code and Its Alterations in Human Disease. Trends Mol Med. 2018;24:886\u2013903.","journal-title":"Trends Mol Med"},{"key":"1254_CR29","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1093\/bioinformatics\/bty191","volume":"34","author":"H Li","year":"2018","unstructured":"Li H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics. 2018;34:3094\u2013100.","journal-title":"Bioinformatics"},{"key":"1254_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","volume":"31","author":"Z Li","year":"2017","unstructured":"Li Z, Weng H, Su R, Weng X, Zuo Z, Li C, et al. FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase. Cancer Cell. 2017;31:127\u201341.","journal-title":"Cancer Cell"},{"key":"1254_CR31","doi-asserted-by":"crossref","unstructured":"Lin H, Wang Y, Wang P, Long F, Wang T. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance. Mol Cancer. 2022;21.","DOI":"10.1186\/s12943-022-01620-x"},{"key":"1254_CR32","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1261\/rna.041178.113","volume":"19","author":"N Liu","year":"2013","unstructured":"Liu N, Parisien M, Dai Q, Zheng G, He C, Pan T. Probing N6-methyladenosine RNA modification status at single nucleotide resolution in mRNA and long noncoding RNA. RNA. 2013;19:1848\u201356.","journal-title":"RNA"},{"key":"1254_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.1432","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10:93\u20135.","journal-title":"Nat Chem Biol"},{"key":"1254_CR34","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/s41556-018-0174-4","volume":"20","author":"J Liu","year":"2018","unstructured":"Liu J, Eckert MA, Harada BT, Liu SM, Lu Z, Yu K, et al. m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat Cell Biol. 2018;20:1074\u201383.","journal-title":"Nat Cell Biol"},{"key":"1254_CR35","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.molcel.2019.09.032","volume":"77","author":"J Liu","year":"2020","unstructured":"Liu J, Li K, Cai J, Zhang M, Zhang X, Xiong X, et al. Landscape and Regulation of m6A and m6Am Methylome across Human and Mouse Tissues. Mol Cell. 2020a;77:426\u2013440.e6.","journal-title":"Mol Cell"},{"key":"1254_CR36","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1002\/1878-0261.12819","volume":"14","author":"J Liu","year":"2020","unstructured":"Liu J, Zhan Y, Wang J, Wang J, Guo J, Kong D. Long noncoding RNA LINC01578 drives colon cancer metastasis through a positive feedback loop with the NF-\u03baB\/YY1 axis. Mol Oncol. 2020b;14:3211\u201333.","journal-title":"Mol Oncol"},{"key":"1254_CR37","first-page":"2513813","volume":"2022","author":"F Liu","year":"2022","unstructured":"Liu F, Zhang X, Liu Z, Cai W, Song C, Jiang Y, et al. M6A Modifier-Mediated Methylation Characterized by Diverse Prognosis, Tumor Microenvironment, and Immunotherapy Response in Hepatocellular Carcinoma. J Oncol. 2022;2022:2513813.","journal-title":"J Oncol"},{"key":"1254_CR38","doi-asserted-by":"crossref","unstructured":"Liu J, Yue Y, Liu J, Cui X, Cao J, Luo G, et al. VIRMA mediates preferential m6A mRNA methylation in 3\u2019UTR and near stop codon and associates with alternative polyadenylation. Cell Discov. 2018;4.","DOI":"10.1038\/s41421-018-0019-0"},{"key":"1254_CR39","doi-asserted-by":"crossref","unstructured":"Liu H, Begik O, Lucas MC, Ramirez JM, Mason CE, Wiener D, et al. Accurate detection of m6A RNA modifications in native RNA sequences. Nature Communications 2019 10:1. 2019;10:1\u20139.","DOI":"10.1038\/s41467-019-11713-9"},{"key":"1254_CR40","doi-asserted-by":"crossref","unstructured":"Ma S, Chen C, Ji X, Liu J, Zhou Q, Wang G, et al. The interplay between m6A RNA methylation and noncoding RNA in cancer. Journal of Hematology & Oncology 2019 12:1. 2019;12:1\u201315.","DOI":"10.1186\/s13045-019-0805-7"},{"key":"1254_CR41","doi-asserted-by":"crossref","unstructured":"Manou D, Golfinopoulou MA, Alharbi SND, Alghamdi HA, Alzahrani FM, Theocharis AD. The Expression of Serglycin Is Required for Active Transforming Growth Factor \u03b2 Receptor I Tumorigenic Signaling in Glioblastoma Cells and Paracrine Activation of Stromal Fibroblasts via CXCR-2. Biomolecules. 2024;14.","DOI":"10.3390\/biom14040461"},{"key":"1254_CR42","doi-asserted-by":"crossref","unstructured":"Matja\u0161i\u010d A, Tajnik M, Bo\u0161tjan\u010di\u010d E, Popovi\u0107 M, Matos B, Glava\u010d D. Identifying Novel Glioma-Associated Noncoding RNAs by Their Expression Profiles. Int J Genomics. 2017;2017.","DOI":"10.1155\/2017\/2312318"},{"key":"1254_CR43","doi-asserted-by":"crossref","unstructured":"McCown PJ, Ruszkowska A, Kunkler CN, Breger K, Hulewicz JP, Wang MC, et al. Naturally occurring modified ribonucleosides. Wiley Interdiscip Rev RNA. 2020;11.","DOI":"10.1002\/wrna.1595"},{"key":"1254_CR44","doi-asserted-by":"crossref","unstructured":"Muzellec B, Tele\u0144czuk M, Cabeli V, Andreux M. PyDESeq2: a python package for bulk RNA-seq differential expression analysis. Bioinformatics. 2023;39.","DOI":"10.1093\/bioinformatics\/btad547"},{"key":"1254_CR45","doi-asserted-by":"crossref","unstructured":"Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016\u20132020. Neuro Oncol. 2023;25 12 Suppl 2:IV1\u201399.","DOI":"10.1093\/neuonc\/noad149"},{"key":"1254_CR46","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nature19342","volume":"537","author":"DP Patil","year":"2016","unstructured":"Patil DP, Chen CK, Pickering BF, Chow A, Jackson C, Guttman M, et al. m(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature. 2016;537:369\u201373.","journal-title":"Nature"},{"key":"1254_CR47","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.tcb.2017.10.001","volume":"28","author":"DP Patil","year":"2018","unstructured":"Patil DP, Pickering BF, Jaffrey SR. Reading m6A in the Transcriptome: m6A-Binding Proteins. Trends Cell Biol. 2018;28:113\u201327.","journal-title":"Trends Cell Biol"},{"key":"1254_CR48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/cr.2014.3","volume":"24","author":"XL Ping","year":"2014","unstructured":"Ping XL, Sun BF, Wang L, Xiao W, Yang X, Wang WJ, et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res. 2014;24:177\u201389.","journal-title":"Cell Res"},{"key":"1254_CR49","doi-asserted-by":"crossref","unstructured":"Rom A, Melamed L, Gil N, Goldrich MJ, Kadir R, Golan M, et al. Regulation of CHD2 expression by the Chaserr long noncoding RNA gene is essential for viability. Nat Commun. 2019;10.","DOI":"10.1038\/s41467-019-13075-8"},{"key":"1254_CR50","doi-asserted-by":"publisher","first-page":"17232","DOI":"10.1038\/s41598-023-44087-6","volume":"13","author":"A Sharma","year":"2023","unstructured":"Sharma A, Wang Y, Ge F, Chen P, Dakal TC, Carro MS, et al. Systematic integration of m6A regulators and autophagy-related genes in combination with long non-coding RNAs predicts survival in glioblastoma multiforme. Sci Rep. 2023;13:17232.","journal-title":"Sci Rep"},{"key":"1254_CR51","doi-asserted-by":"publisher","unstructured":"Sharma A, Dakal TC, Schmidt-Wolf IGH, Maciaczyk J, Steponaitis G. Edge of RNA m6A modification on LINE-1 retrotransposons in central nervous system: merely a transcriptional control? Epigenomics. 2025. https:\/\/doi.org\/10.1080\/17501911.2025.2479424.","DOI":"10.1080\/17501911.2025.2479424"},{"key":"1254_CR52","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","volume":"74","author":"H Shi","year":"2019","unstructured":"Shi H, Wei J, He C. Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers. Mol Cell. 2019;74:640\u201350.","journal-title":"Mol Cell"},{"key":"1254_CR53","doi-asserted-by":"crossref","unstructured":"Sj\u00f6stedt E, Zhong W, Fagerberg L, Karlsson M, Mitsios N, Adori C,\u00a0et al. An atlas of the protein-coding genes in the human, pig, and mouse brain. Science. 2020;367.","DOI":"10.1126\/science.aay5947"},{"key":"1254_CR54","doi-asserted-by":"crossref","unstructured":"Steponaitis G, Stakaitis R, Valiulyte I, Krusnauskas R, Dragunaite R, Urbanavi\u010di\u016bt\u0117 R, et al. Transcriptome-wide analysis of glioma stem cell specific m6A modifications in long-non-coding RNAs. Sci Rep. 2022;12.","DOI":"10.1038\/s41598-022-08616-z"},{"key":"1254_CR55","doi-asserted-by":"crossref","unstructured":"Sun T, Wu R, Ming L. The role of m6A RNA methylation in cancer. Biomed Pharmacother. 2019;112.","DOI":"10.1016\/j.biopha.2019.108613"},{"key":"1254_CR56","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.3892\/mmr.2014.2549","volume":"10","author":"Y Takahashi","year":"2014","unstructured":"Takahashi Y, Makino K, Nakamura H, Hide T, Yano S, Kamada H, et al. Clinical characteristics and pathogenesis of cerebellar glioblastoma. Mol Med Rep. 2014;10:2383\u20138.","journal-title":"Mol Med Rep"},{"key":"1254_CR57","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1021\/acs.biochem.8b00949","volume":"58","author":"R Thapar","year":"2019","unstructured":"Thapar R, Bacolla A, Oyeniran C, Brickner JR, Chinnam NB, Mosammaparast N, et al. RNA Modifications: Reversal Mechanisms and Cancer. Biochemistry. 2019;58:312\u201329.","journal-title":"Biochemistry"},{"key":"1254_CR58","doi-asserted-by":"crossref","unstructured":"Venteicher AS, Tirosh I, Hebert C, Yizhak K, Neftel C, Filbin MG, et al. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science. 2017;355.","DOI":"10.1126\/science.aai8478"},{"key":"1254_CR59","doi-asserted-by":"crossref","unstructured":"Visvanathan A, Patil V, Abdulla S, Hoheisel JD, Somasundaram K. N6-Methyladenosine Landscape of Glioma Stem-Like Cells: METTL3 Is Essential for the Expression of Actively Transcribed Genes and Sustenance of the Oncogenic Signaling. Genes (Basel). 2019;10.","DOI":"10.3390\/genes10020141"},{"key":"1254_CR60","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1007\/s00417-010-1417-7","volume":"248","author":"AE Volk","year":"2010","unstructured":"Volk AE, Fricke J, Strobl J, Kolling G, Kubisch C, Neugebauer A. Analysis of the CHN1 gene in patients with various types of congenital ocular motility disorders. Graefes Arch Clin Exp Ophthalmol. 2010;248:1351\u20137.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1254_CR61","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nm.4416","volume":"23","author":"LP Vu","year":"2017","unstructured":"Vu LP, Pickering BF, Cheng Y, Zaccara S, Nguyen D, Minuesa G, et al. The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med. 2017;23:1369\u201376.","journal-title":"Nat Med"},{"key":"1254_CR62","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature12730","volume":"505","author":"X Wang","year":"2014","unstructured":"Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505:117\u201320.","journal-title":"Nature"},{"key":"1254_CR63","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.stem.2018.03.011","volume":"22","author":"X Wang","year":"2018","unstructured":"Wang X, Prager BC, Wu Q, Kim LJY, Gimple RC, Shi Y, et al. Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression. Cell Stem Cell. 2018;22:514\u2013528.e5.","journal-title":"Cell Stem Cell"},{"key":"1254_CR64","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10143-020-01238-x","volume":"44","author":"W Wang","year":"2021","unstructured":"Wang W, Li J, Lin F, Guo J, Zhao J. Identification of N 6-methyladenosine-related lncRNAs for patients with primary glioblastoma. Neurosurg Rev. 2021;44:463\u201370.","journal-title":"Neurosurg Rev"},{"key":"1254_CR65","doi-asserted-by":"crossref","unstructured":"Wang H, Yin M, Ye L, Gao P, Mao X, Tian X, et al. S100A11 Promotes Glioma Cell Proliferation and Predicts Grade-Correlated Unfavorable Prognosis. Technol Cancer Res Treat. 2021;20.","DOI":"10.1177\/15330338211011961"},{"key":"1254_CR66","doi-asserted-by":"crossref","unstructured":"Wang S, Lv W, Li T, Zhang S, Wang H, Li X, et al. Dynamic regulation and functions of mRNA m6A modification. Cancer Cell Int. 2022;22.","DOI":"10.1186\/s12935-022-02452-x"},{"key":"1254_CR67","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ceb.2020.11.005","volume":"70","author":"J Wei","year":"2021","unstructured":"Wei J, He C. Chromatin and transcriptional regulation by reversible RNA methylation. Curr Opin Cell Biol. 2021;70:109\u201315.","journal-title":"Curr Opin Cell Biol"},{"key":"1254_CR68","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","volume":"22","author":"H Weng","year":"2018","unstructured":"Weng H, Huang H, Wu H, Qin X, Zhao BS, Dong L, et al. METTL14 Inhibits Hematopoietic Stem\/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification. Cell Stem Cell. 2018;22:191\u2013205.e9.","journal-title":"Cell Stem Cell"},{"key":"1254_CR69","doi-asserted-by":"crossref","unstructured":"Xie J, Huang Z, Jiang P, Wu R, Jiang H, Luo C, et al. Elevated N6-Methyladenosine RNA Levels in Peripheral Blood Immune Cells: A Novel Predictive Biomarker and Therapeutic Target for Colorectal Cancer. Front Immunol. 2021;12.","DOI":"10.3389\/fimmu.2021.760747"},{"key":"1254_CR70","doi-asserted-by":"crossref","unstructured":"Yen YP, Chen JA. The m6A epitranscriptome on neural development and degeneration. J Biomed Sci. 2021;28.","DOI":"10.1186\/s12929-021-00734-6"},{"key":"1254_CR71","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20:608\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1254_CR72","doi-asserted-by":"crossref","first-page":"E2047","DOI":"10.1073\/pnas.1521518113","volume":"113","author":"C Zhang","year":"2016","unstructured":"Zhang C, Samanta D, Lu H, Bullen JW, Zhang H, Chen I, et al. Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA. Proc Natl Acad Sci U S A. 2016a;113:E2047\u201356.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1254_CR73","doi-asserted-by":"publisher","first-page":"64527","DOI":"10.18632\/oncotarget.11743","volume":"7","author":"C Zhang","year":"2016","unstructured":"Zhang C, Zhi WI, Lu H, Samanta D, Chen I, Gabrielson E, et al. Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells. Oncotarget. 2016b;7:64527\u201342.","journal-title":"Oncotarget"},{"key":"1254_CR74","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ccell.2017.02.013","volume":"31","author":"S Zhang","year":"2017","unstructured":"Zhang S, Zhao BS, Zhou A, Lin K, Zheng S, Lu Z, et al. m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. Cancer Cell. 2017;31:591\u2013606.e6.","journal-title":"Cancer Cell"},{"key":"1254_CR75","doi-asserted-by":"crossref","unstructured":"Zhao H, Wang L, Wang S, Chen X, Liang M, Zhang X, et al. CHN1 promotes epithelial-mesenchymal transition via the Akt\/GSK-3\u03b2\/Snail pathway in cervical carcinoma. J Transl Med. 2021;19.","DOI":"10.1186\/s12967-021-02963-7"},{"key":"1254_CR76","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nature15377","volume":"526","author":"J Zhou","year":"2015","unstructured":"Zhou J, Wan J, Gao X, Zhang X, Jaffrey SR, Qian SB. Dynamic m(6)A mRNA methylation directs translational control of heat shock response. Nature. 2015;526:591\u20134.","journal-title":"Nature"},{"key":"1254_CR77","doi-asserted-by":"crossref","unstructured":"Zhou KI, Parisien M, Dai Q, Liu N, Diatchenko L, Sachleben JR, et al. N(6)-Methyladenosine Modification in a Long Noncoding RNA Hairpin Predisposes Its Conformation to Protein Binding. J Mol Biol. 2016;428 5 Pt A:822\u201333.","DOI":"10.1016\/j.jmb.2015.08.021"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01254-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-025-01254-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01254-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T10:03:53Z","timestamp":1747476233000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-025-01254-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,17]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1254"],"URL":"https:\/\/doi.org\/10.1186\/s10020-025-01254-x","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,17]]},"assertion":[{"value":"9 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Ethical Principles for Medical Research Involving Human Subjects (Declaration of Helsinki), and the research was approved by the Kaunas Regional Biomedical Research Ethics Committee (No P2-9\/2003 and BE-2\u201326-2021). Written informed consent was obtained from each participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from each participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"195"}}